{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-024431","form_type":"8-K","ticker":"INO","cik":"0001055726","company_name":"INOVIO PHARMACEUTICALS, INC.","filed_at":"2026-01-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.475500+00:00","generated_at":"2026-05-16T07:23:15.123288+00:00","sec_items":["1.01","3.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Inovio extends Series A Warrant expiration to March 31, 2026","bullets":["Amendment extends expiration of Series A Warrants (up to 13,564,268 shares) from Jan 28, 2026 to March 31, 2026.","Warrants issued in July 2025 public offering; exercise price $1.75/share (pre-funded at $0.001).","Original expiration was 30 days after FDA BLA acceptance for INO-3107; extension provides additional exercise window.","All other warrant terms remain unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-024431","json":"https://secwatch.observer/filing/0001193125-26-024431.json","markdown":"https://secwatch.observer/filing/0001193125-26-024431.md","text":"https://secwatch.observer/filing/0001193125-26-024431.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1055726/000119312526024431/0001193125-26-024431-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1055726/000119312526024431/d63939d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T07:23:15.123288+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c8b0a78db4809626657795c5caff3b968d945ad1","claim":"INOVIO PHARMACEUTICALS, INC. amended Series A Warrants (effective 2026-01-27).","evidence_excerpt":"On January 27, 2026, Inovio Pharmaceuticals, Inc. (the “Company”) amended each of its outstanding Series A warrants issued on July 7, 2025 (the “Series A Warrants”) to extend the expiration date","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1055726/000119312526024431/0001193125-26-024431-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Effective","value":"2026-01-27"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}